9 results on '"Porcaro F"'
Search Results
2. A smartphone app for preschool wheezing and reliability of medical history collection.
- Author
-
Ullmann N, Fracchiolla A, Boni A, Negro V, Porcaro F, Di Marco A, Tripodi S, and Cutrera R
- Subjects
- Humans, Male, Female, Child, Preschool, Reproducibility of Results, Child, Medical History Taking, Feasibility Studies, Surveys and Questionnaires, Mobile Applications, Respiratory Sounds, Smartphone, Asthma therapy, Asthma diagnosis
- Abstract
Background: The use of mobile applications helps improving self-management in adolescents with asthma. However, no evidence is available for children with preschool wheezing. In addition, we have no data on the reliability of medical history collected at visits. The first aim was to assess the feasibility of a smartphone app in the management of preschool wheezing; secondly we aimed to evaluate the reliability of anamnestic data collected during face-to-face medical interviews., Methods: Children with recurrent wheezing, age between 25 and 72 months, were randomly assigned to the intervention group, provided with a smartphone app for symptoms monitoring and asthma attack treatment, or to the control group, with a written action plan. At follow-up medical history was collected and the asthma control test and a clinical questionnaire were completed. App acceptability was also explored. Respiratory symptoms, medication and utilization of healthcare resources were collected. Plus, medical information obtained from the paper questionnaires was compared with data daily recorded by the app., Results: We enrolled 85 preschool children with recurrent wheezing: 43 assigned to the intervention and 42 to the control group. The average (SD) adherence to e-Diary compilation was 60 (15)%. The acceptance and usability of the intervention was favorable as 70% and 93% of participants in the intervention arm described the app as ''simple and intuitive'' at Visit1 (after 3 months from enrollement) and Visit2 (3 months later than Visit1), respectively and 95% and 98% found it useful in symptoms management. There were no significant differences between the two groups in clinical outcomes. At Visit1, the cACT median score (IQR) was 23,5 (21-25) for the control group (42 patients) and 23 (21-24) for the intervention group (43 patients). At Visit2 (41 controls and 42 in the intervention group) it was 25 (24-25) and 24 (24-25), respectively. Secondary analysis of data from the intervention group showed higher incidence of daily symptoms recorded by the app in comparison with the paper questionnaire, suggesting that collection of retrospective medical history may not be completely reliable., Conclusions: The smartphone app is usable and acceptable by families of preschool wheezers. Future controlled trial are needed to prove an impact on clinical outcomes or its efficacy in a telemedicine program. Finally a daily questionnaire could provide physicians with a more reliable clinical picture as reflected better daily asthma symptoms than the written retrospective questionnaire filled at clinical visit., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
3. Bronchiolitis guidelines: what about the Italian situation in a primary care setting?
- Author
-
Porcaro F, Cutrera R, Vittucci AC, and Villani A
- Subjects
- Child, Humans, Anti-Bacterial Agents, Italy, Primary Health Care, Bronchiolitis, Viral, Bronchiolitis diagnosis, Bronchiolitis therapy
- Abstract
Acute viral bronchiolitis is the most common cause of hospitalization in children under 12 months of age. The variable clinical presentation and the potential for sudden deterioration of the clinical conditions require a close monitoring by healthcare professionals.In Italy, first access care for children is provided by primary care physicians (PCPs) who often must face to a heterogeneous disease presentation that, in some cases, make the management of patient with bronchiolitis challenging. Consequently, Italian studies report poor adherence to national and international guidelines processed to guide the clinicians in decision making in acute viral bronchiolitis.This paper aims to identify the potential factors contributing to the lack of adherence to the suggested guidelines derived by clear and evidence-based recommendations among primary care physicians operating in an outpatient setting, with a specific focus on the context of Italy. Particularly, we focus on the prescription of medications such as β2-agonists, systemic steroids, and antibiotics which are commonly prescribed by PCPs to address conditions that can mimic bronchiolitis., (© 2023. Società Italiana di Pediatria.)
- Published
- 2023
- Full Text
- View/download PDF
4. Long term respiratory morbidity in patients with vascular rings: a review.
- Author
-
Porcaro F, Ciliberti P, Petreschi F, Secinaro A, Allegorico A, Coretti A, and Cutrera R
- Subjects
- Child, Humans, Infant, Aorta, Thoracic, Respiratory Sounds, Morbidity, Vascular Ring, Respiratory Tract Infections
- Abstract
Abnormalities in position and/or branching of the aortic arch can lead to vascular rings that may cause narrowing of the tracheal lumen due to external compression, or constriction of the oesophagus, causing symptoms that vary in relation to the anatomical vascular pattern and the relationship between these structures. Respiratory morbidity related to external airways compression is a major concern in children affected by vascular rings. Clinical presentation depends on the severity of the tracheal lumen reduction and the presence of associated tracheomalacia. Recurrent respiratory infections, wheezing, atelectasis, and hyperinflation are mostly reported. As they are nonspecific and therefore difficult to recognize, attention should be given to all children with history of respiratory distress, extubation failure, noisy breathing, and recurrent respiratory infections. Early diagnosis and referral to specialized centres can prevent the long-term complications and improve the respiratory outcomes of these patients., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
5. Two novel mutations in exon 3 of PHOX2B gene: think about congenital central hypoventilation syndrome in patients with Hirschsprung disease.
- Author
-
Paglietti MG, Cherchi C, Porcaro F, Agolini E, Schiavino A, Petreschi F, Novelli A, and Cutrera R
- Subjects
- Adult, Female, Humans, Hypoventilation genetics, Infant, Male, Exons, Hirschsprung Disease complications, Homeodomain Proteins genetics, Hypoventilation congenital, Mutation, Sleep Apnea, Central genetics, Transcription Factors genetics
- Abstract
Background: Congenital central hypoventilation syndrome (CCHS) is characterized by alveolar hypoventilation increasing during sleep and affected patients are unable to perceive and respond to hypercarbia with increased ventilation and arousal during sleep. PHOX2B gene mutations are considered as responsible for CCHS. Most of patients with CCHS are heterozygous for polyalanine expansion mutations (PARMs) in exon 3, but 10% of patients with classic CCHS are heterozygous for non-polyalanine expansion mutations (NPARMs) of the PHOX2B gene., Methods: Data are collected on 3 patients affected by CCHS who referred to the Paediatric Pulmonology Unit of Bambino Gesù Children's Hospital (Rome, Italy) for a multidisciplinary follow-up program between 2000 and 2017., Results: We describe three cases of patients affected by CCHS for which two novel mutations on exon 3 of PHOX2B gene were detected., Conclusions: The description of these novel mutations and related clinical phenotypes allows to expand the knowledge into NPARM spectrum. Since the presence of Hirschsprung disease is related to NPARMs and the number of alanine repeats, we suggest performing CCHS genetic investigation and periodical assessment also in patients without a clear history of CCHS but affected by Hirschsprung disease., Trial Registration: Data are retrospectively collected.
- Published
- 2019
- Full Text
- View/download PDF
6. Pleural effusion from intrathoracic migration of a ventriculo-peritoneal shunt catheter: pediatric case report and review of the literature.
- Author
-
Porcaro F, Procaccini E, Paglietti MG, Schiavino A, Petreschi F, and Cutrera R
- Subjects
- Acrocephalosyndactylia complications, Acrocephalosyndactylia surgery, Catheters adverse effects, Child, Preschool, Female, Follow-Up Studies, Foreign-Body Migration complications, Foreign-Body Migration surgery, Humans, Hydrocephalus complications, Hydrocephalus diagnostic imaging, Magnetic Resonance Imaging methods, Pleural Effusion diagnostic imaging, Pleural Effusion etiology, Reoperation methods, Risk Assessment, Tomography, X-Ray Computed methods, Treatment Outcome, Ventriculoperitoneal Shunt methods, Acrocephalosyndactylia diagnosis, Device Removal methods, Foreign-Body Migration diagnostic imaging, Hydrocephalus surgery, Pleural Effusion surgery, Ventriculoperitoneal Shunt instrumentation
- Abstract
Background: Pleural effusion is a rare complication of ventriculo-peritoneal (VP) cerebrospinal fluid (CSF) shunting and its diagnosis is difficult in patients with neurological and consciousness impairment., Case Report: Herein we report the case of a child affected by Pfeiffer syndrome and hydrocephalus, shunted at the age of 3 months, who developed acute respiratory failure due to a right-sided pleural effusion 2 years later. Plain chest radiographs and computed tomography (CT) showed the intrathoracic migration of the right VP shunt abdominal tip. Beta-2 transferrin, a marker for CSF, was found in the pleural fluid and the hypothesis of a CSF hydrothorax was confirmed. Effusion was treated with a thoracentesis. Seven days after, the right VP shunt was revised; a ventriculo-atrial (VA) shunt was also placed on the left side to serve as the main CSF shunt and to prevent the recurrence of hydrothorax. We review the pediatric cases of CSF hydrothorax reported in the literature and discuss the mechanisms underlying this complication together with the possible treatments., Conclusion: Pleural effusion due to VP shunt insertion is a rare and potentially life-threatening condition that should be suspected in any patient with a VP shunt and respiratory failure. Signs of hydrothorax may moreover represent the only clinical evidence of a shunt-related complication in case of neurologically severely compromised patients in which neurologic examination cannot help to make a diagnosis.
- Published
- 2018
- Full Text
- View/download PDF
7. Anaphylactic shock with methylprednisolone sodium succinate in a child with short bowel syndrome and cow's milk allergy.
- Author
-
Porcaro F, Paglietti MG, Diamanti A, Petreschi F, Schiavino A, Negro V, Pecora V, Fiocchi A, and Cutrera R
- Subjects
- Anaphylaxis drug therapy, Anaphylaxis physiopathology, Animals, Cattle, Emergency Service, Hospital, Follow-Up Studies, Histamine Antagonists therapeutic use, Humans, Infant, Injections, Intravenous, Male, Methylprednisolone Hemisuccinate therapeutic use, Milk Hypersensitivity complications, Respiratory Insufficiency diagnosis, Risk Assessment, Short Bowel Syndrome complications, Treatment Outcome, Anaphylaxis chemically induced, Methylprednisolone Hemisuccinate adverse effects, Milk Hypersensitivity diagnosis, Respiratory Insufficiency drug therapy, Short Bowel Syndrome diagnosis
- Abstract
Background: Medications with methyl-prednisolone sodium succinate containing lactose, which potentially contains traces of cow's milk proteins (CMP), could cause allergic reactions or compromise treatment of acute allergic reactions in sensitized patients., Case Presentation: We describe the unusual case of a one-year-old child affected by short bowel syndrome and history of severe cow's milk allergy (CMA) and anaphylactic reaction due to intravenous administration of methyl-prednisolone sodium succinate (Solu-Medrol 40 mg, Pfizer). He was admitted to our hospital for severe respiratory failure and was initially treated with methyl-prednisolone (Urbason 40 mg, Sanofi Aventis), then with methyl-prednisolone sodium succinate (Solu-Medrol 40 mg, Pfizer). After the intravenous administration of second steroid, immediate anaphylaxis was recorded and treatment was stopped. Antihistamine and epinephrine were required and symptom resolution occurred., Conclusion: Children who are highly sensitive to milk may have severe allergic reactions also after exposure to CMP through a different administration route than the oral one. Patients who have food allergies need to pay particular attention to the prescription of drugs and their formulation.
- Published
- 2017
- Full Text
- View/download PDF
8. Respiratory problems in children with esophageal atresia and tracheoesophageal fistula.
- Author
-
Porcaro F, Valfré L, Aufiero LR, Dall'Oglio L, De Angelis P, Villani A, Bagolan P, Bottero S, and Cutrera R
- Subjects
- Age Distribution, Bronchoscopy methods, Child, Child, Preschool, Cohort Studies, Databases, Factual, Esophageal Atresia diagnosis, Esophageal Atresia surgery, Female, Hospitals, Pediatric, Humans, Incidence, Infant, Italy epidemiology, Male, Prognosis, Respiratory Tract Diseases epidemiology, Respiratory Tract Diseases physiopathology, Retrospective Studies, Risk Assessment, Severity of Illness Index, Sex Distribution, Tracheoesophageal Fistula diagnosis, Tracheoesophageal Fistula surgery, Esophageal Atresia complications, Respiratory Tract Diseases etiology, Tracheoesophageal Fistula complications
- Abstract
Background: Children with congenital esophageal atresia (EA) and tracheoesophageal fistula (TEF) have chronic respiratory symptoms including recurrent pneumonia, wheezing and persistent cough. The aim of this study is to describe the clinical findings of a large group of children with EA and TEF surgically corrected and the instrumental investigation to which they have undergone in order to better understand the patient's needs and harmonize the care., Methods: A retrospective data collection was performed on 105 children with EA and TEF followed at Department of Pediatric Medicine of Bambino Gesù Children's Hospital (Rome, Italy) between 2010 and 2015., Results: 69/105 (66%) children reported lower respiratory symptoms with a mean age onset of 2.2 ± 2.5 years and only 63/69 (91%) performed specialist assessment at Respiratory Unit. Recurrent pneumonia (33%) and wheezing (31%) were the most reported symptoms. The first respiratory evaluation was performed after surgically correction of gastroesophageal reflux (GER) at mean age of 3.9 ± 4.2 years. Twenty nine patients have undergone to chest CT with contrast enhancement detecting localized atelectasis (41%), residual tracheal diverticulum (34%), bronchiectasis (31%), tracheal vascular compression (21%), tracheomalacia (17%) and esophageal diverticulum (14%). Fifty three patients have undergone to airways endoscopy detecting tracheomalacia (66%), residual tracheal diverticulum (26%), recurrent tracheoesophageal fistula (19%) and vocal cord paralysis (11%)., Conclusions: Our study confirms that respiratory symptoms often complicate EA and TEF; their persistence despite medical and surgical treatment of GER means that other etiological hypothesis must be examined and that a complete respiratory diagnostic work up must be considered.
- Published
- 2017
- Full Text
- View/download PDF
9. Food protein induced enterocolitis syndrome caused by rice beverage.
- Author
-
Caminiti L, Salzano G, Crisafulli G, Porcaro F, and Pajno GB
- Subjects
- Acidosis etiology, Beverages, Diarrhea etiology, Double-Blind Method, Emergencies, Enterocolitis complications, Enterocolitis therapy, Fluid Therapy, Food Hypersensitivity etiology, Food Hypersensitivity immunology, Food Hypersensitivity therapy, Glucocorticoids therapeutic use, Humans, Hypotension etiology, Infant, Male, Oryza immunology, Treatment Outcome, Vomiting etiology, Enterocolitis diagnosis, Enterocolitis immunology, Food Hypersensitivity complications, Food Hypersensitivity diagnosis, Oryza adverse effects
- Abstract
Food protein-induced enterocolitis syndrome (FPIES) is an uncommon and potentially severe non IgE-mediated gastrointestinal food allergy. It is usually caused by cow's milk or soy proteins, but may also be triggered by ingestion of solid foods. The diagnosis is made on the basis of clinical history and symptoms. Management of acute phase requires fluid resuscitation and intravenous steroids administration, but avoidance of offending foods is the only effective therapeutic option.Infant with FPIES presented to our emergency department with vomiting, watery stools, hypothension and metabolic acidosis after ingestion of rice beverage. Intravenous fluids and steroids were administered with good clinical response. Subsequently, a double blind placebo control food challenge (DBPCFC) was performed using rice beverage and hydrolyzed formula (eHF) as placebo. The "rice based formula" induced emesis, diarrhoea and lethargy. Laboratory investigations reveal an increase of absolute count of neutrophils and the presence of faecal eosinophils. The patient was treated with both intravenous hydration and steroids. According to Powell criteria, oral food challenge was considered positive and diagnosis of FPIES induced by rice beverage was made. Patient was discharged at home with the indication to avoid rice and any rice beverage as well as to reintroduce hydrolyzed formula. A case of FPIES induced by rice beverage has never been reported. The present case clearly shows that also beverage containing rice proteins can be responsible of FPIES. For this reason, the use of rice beverage as cow's milk substitute for the treatment of non IgE-mediated food allergy should be avoided.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.